Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Legend Biotech (LEGN) Shares Outstanding (Weighted Average): 2019-2025

Historic Shares Outstanding (Weighted Average) for Legend Biotech (LEGN) over the last 6 years, with Sep 2025 value amounting to $369.1 million.

  • Legend Biotech's Shares Outstanding (Weighted Average) rose 1.24% to $369.1 million in Q3 2025 from the same period last year, while for Mar 2022 it was $308.5 million, marking a year-over-year increase of 15.83%. This contributed to the annual value of $366.9 million for FY2024, which is 0.91% up from last year.
  • Latest data reveals that Legend Biotech reported Shares Outstanding (Weighted Average) of $369.1 million as of Q3 2025, which was up 0.29% from $368.1 million recorded in Q2 2025.
  • In the past 5 years, Legend Biotech's Shares Outstanding (Weighted Average) ranged from a high of $369.1 million in Q3 2025 and a low of $266.3 million during Q1 2021.
  • For the 3-year period, Legend Biotech's Shares Outstanding (Weighted Average) averaged around $359.2 million, with its median value being $364.6 million (2024).
  • Data for Legend Biotech's Shares Outstanding (Weighted Average) shows a peak YoY climbed of 17.78% (in 2023) over the last 5 years.
  • Over the past 5 years, Legend Biotech's Shares Outstanding (Weighted Average) (Quarterly) stood at $290.7 million in 2021, then climbed by 6.21% to $308.7 million in 2022, then climbed by 17.78% to $363.6 million in 2023, then grew by 0.91% to $366.9 million in 2024, then rose by 1.24% to $369.1 million in 2025.
  • Its Shares Outstanding (Weighted Average) stands at $369.1 million for Q3 2025, versus $368.1 million for Q2 2025 and $367.3 million for Q1 2025.